Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Whither goest Kt/V?

F A Gotch1, J A Sargent, M L Keen

  • 1Quantitative Medical Systems, Emeryville, California, USA. fgotchsf@cs.com

Kidney International. Supplement
|August 11, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clarification and confocal imaging of the nonhuman primate placental micro-anatomy.

BioTechniques·2018
Same author

The localization of 2,4-D in leaf tissue.

Planta·2014
Same author

Orientation of cell growth in the etiolated pea stem : Effect of ethylene and auxin on cell wall deposition.

Planta·2014
Same author

Auxin and ethylene control of growth in epidermal cells of Pisum sativum: A biphasic response to auxin.

Planta·2014
Same author

An effect of ethylene on the endoplasmic reticulum of expanding cells of etiolated shoots of Pisum sativum L.

Planta·2014
Same author

The positional differentiation of ethylene-responsive cells in rachis abscission zones in leaves of Sambucus nigra and their growth and ultrastructural changes at senescence and separation.

Planta·2014
Same journal

Effect of kidney disease on glucose handling (including genetic defects).

Kidney international. Supplement·2011
Same journal

Need for better diabetes treatment for improved renal outcome.

Kidney international. Supplement·2011
Same journal

Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.

Kidney international. Supplement·2011
Same journal

SGLT2 inhibitors: molecular design and potential differences in effect.

Kidney international. Supplement·2011
Same journal

Glucose handling by the kidney.

Kidney international. Supplement·2011
Same journal

Bone: from a reservoir of minerals to a regulator of energy metabolism.

Kidney international. Supplement·2011
See all related articles

Dialysis effectively removes uremic toxins, with urea clearance (Kt/V) quantifying treatment efficacy for low molecular weight solutes. This metric is predicted to expand for other toxins like beta-2 microglobulin as uremic toxicity understanding grows.

Area of Science:

  • Nephrology
  • Biochemistry
  • Clinical Medicine

Background:

  • Uremia involves body water contamination with retained solutes, leading to concentration-dependent toxicity.
  • Kidney failure necessitates dialysis to remove these toxic solutes.
  • Understanding solute-specific uremic toxicity beyond fluid, electrolyte, and beta-2 microglobulin is limited.

Purpose of the Study:

  • To review evidence on uremic syndrome management through dialysis.
  • To establish urea as a surrogate marker for quantifying dialysis clearance of low molecular weight solutes (Kt/V).
  • To explore the relationship between urea generation and other uremic toxins.

Main Methods:

  • Review of existing evidence on uremic toxicity and dialysis.
  • Kinetic modeling to assess solute clearance and dialysis dose (Kt/V).

Related Experiment Videos

  • Analysis of urea's role as a generic marker for low molecular weight solute removal.

    • Main Results:

    • Adequate dialysis of low molecular weight solutes controls many uremic syndrome aspects.
    • Urea clearance (Kt/V) effectively quantifies fractional clearance of body water for retained low molecular weight solutes.
    • Urea lacks concentration-dependent toxicity, and its generation rate is not proportional to other toxic solute generation.

    Conclusions:

    • Kt/V is a valuable metric for dialysis dose equivalency between intermittent and continuous therapies.
    • Kt/V is predicted to generalize for other solutes, including beta-2 microglobulin, as uremic toxicity knowledge advances.
    • Further research into solute-specific uremic toxicity is crucial for refining dialysis strategies.